Famotidine
SIGMA/F6889
Synonym: N′-(Aminosulfonyl)-3-([2-(diaminomethyleneamino)-4-thiazolyl]methylthio)propanamidine
CAS Number: 76824-35-6
Empirical Formula (Hill Notation): C8H15N7O2S3
Molecular Weight: 337.45
MDL Number: MFCD00079297
Linear Formula: C8H15N7O2S3
Product Type: Chemical
| InChI | 1S/C8H15N7O2S3/c9-6(15-20 |
| InChI key | XUFQPHANEAPEMJ-UHFFFAOYSA |
| originator | Johnson & Johnson |
| Quality Level | 100 ![]() |
| SMILES string | NC(N)=Nc1nc(CSCCC(=N)NS |
| Application: | Famotidine has been used to test its effect on the human ether-a-go-go-related gene (hERG) binding transfected in HEK293 membrane. It has also been used in polycaprolactone based drug delivery studies. |
| Biochem/physiol Actions: | Famotidine is not effective on muscarinic and nicotinic receptors. It competitively inhibits the secretion of gastric acid and elicits mucosal injury protection. |
| Biochem/physiol Actions: | H2 histamine receptor antagonist; anti-ulcer agent |
| Features and Benefits: | This compound was developed by Johnson & Johnson . To browse the list of other pharma-developed compounds and Approved Drugs/Drug Candidates, click here . |
| RIDADR | NONH for all modes of transport |
| WGK Germany | WGK 2 |
| Flash Point(F) | Not applicable |
| Flash Point(C) | Not applicable |
| UNSPSC | 12352200 |

